Vertex Pharmaceuticals Inc (VRTX)
408.18
+2.91
(+0.72%)
USD |
NASDAQ |
Dec 24, 16:00
Vertex Pharmaceuticals Cash from Investing (Quarterly): -348.00M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Eli Lilly and Co | -4.005B |
| Gilead Sciences Inc | -710.00M |
| Bristol-Myers Squibb Co | -219.00M |
| Pfizer Inc | -2.057B |
| PTC Therapeutics Inc | -42.68M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 1.370B |
| Cash from Financing (Quarterly) | -387.50M |
| Free Cash Flow | -1.352B |
| Free Cash Flow Per Share (Quarterly) | 4.989 |
| Free Cash Flow to Equity (Quarterly) | 1.302B |
| Free Cash Flow to Firm (Quarterly) | 1.302B |
| Free Cash Flow Yield | -1.27% |